Could Momordica Charantia Be Effective In The Treatment of COVID19?

Basit Öğe Kaydı
dc.contributor.authorTüzün, Burak
dc.contributor.authorSayin, Koray
dc.contributor.authorAtaseven, Hilmi
dc.date.accessioned2025-05-04T16:18:49Z
dc.date.available2025-05-04T16:18:49Z
dc.date.issued2022
dc.departmentSivas Cumhuriyet Üniversitesi
dc.descriptionrgd020
dc.description.abstractOne of the deadliest diseases is the SARS-CoV-2 virus, today. The rate of spread of this virus is very high. Momordica Charantia extracts studied for this virus. The inhibitory activities of 96 components in the extract of Momordica Charantia were compared against the SARS-CoV-2 virus. Molecular docking method was initially used for this comparison. ADME/T analysis of the inhibitors with the highest inhibitory activity was performed using the results obtained from these calculations. The molecular docking calculations of the molecule with the highest inhibitory activity were tried to be supported by MM-PBSA calculations. The molecular mechanics Poisson-Boltzmann surface binding free energy values of area (MM-PBSA) calculations study interactions between inhibitor molecules and SARS-CoV-2 virus proteins at 100 ps. Finally, the molecules with the highest inhibitory activity were compared with FDA approved drugs. As a result of the made molecular docking calculations, the docking score parameter is Karaviloside III with -9.36, among the extracts of momordica charantia, which has the most negative value. The Gibbs free energy value of the Karaviloside III against 6X6P protein with the best docking score value was calculated. This value is -477143.61±476.53. As a result of the comparison of inhibitory activities of extracts of Momordica charantia against SARS-CoV-2 virus, it has been observed that the Karaviloside III molecule has higher inhibitory activity than other melodies and FDA drugs.
dc.description.abstract[No abstract available]
dc.description.sponsorshipsivas cumhuriyet üniversite
dc.identifier.doi10.17776/csj.1009906
dc.identifier.doihttps://doi.org/10.17776/csj.1009906
dc.identifier.endpage220
dc.identifier.issn2587-2680
dc.identifier.issn2587-246X
dc.identifier.issue2
dc.identifier.startpage211
dc.identifier.urihttps://hdl.handle.net/20.500.12418/31143
dc.identifier.volume43
dc.language.isoen
dc.publisherSivas Cumhuriyet University
dc.relation.ispartofCumhuriyet Science Journal
dc.relation.publicationcategoryMakale - Ulusal Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/openAccess
dc.snmzKA_DergiPark_20250504
dc.subjectSARS-CoV-2
dc.subjectMolecular docking
dc.subjectCOVID-19
dc.subjectMomordica charantia
dc.subjectADME/T .
dc.titleCould Momordica Charantia Be Effective In The Treatment of COVID19?
dc.typeResearch Article

Dosyalar

Koleksiyon

DergiPark